S-1 Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q3 2021

Filing Information

Form Type	S-1
Accession Number	`0001628280-21-023544`
Period End Date	20210930
Filing Date	20211116
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	prva-20211116_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 108 Income Statement 130 Cash Flow Statement 192 Stockholders Equity 53

Balance Sheet 108 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$362.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$84.63M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.89M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$77.34M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$99.12M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$98.38M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.93M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.37M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$469.42M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$190.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$129.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.81M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.62M	USD	Point-in-time
Related party receivables	`DueFromRelatedPartiesNoncurrent`	-	USD	Point-in-time
Related party receivables	`DueFromRelatedPartiesNoncurrent`	$4.03M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.38M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$6.62M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.50M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.98M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$25.37M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$4.95M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	-	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.47M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$5.67M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.38M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$140.61M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$162.64M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$138.88M	USD	Point-in-time
Total assets	`Assets`	$270.20M	USD	Point-in-time
Total assets	`Assets`	$328.97M	USD	Point-in-time
Total assets	`Assets`	$632.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$525.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.27M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$27.94M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.30M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.18M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$106.81M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$145.00M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$82.27M	USD	Point-in-time
Current portion of notes payable to related parties	`NotesPayableRelatedPartiesClassifiedCurrent`	-	USD	Point-in-time
Current portion of notes payable to related parties	`NotesPayableRelatedPartiesClassifiedCurrent`	$2.50M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.20M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$4.60M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.11M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$146.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$115.22M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$187.24M	USD	Point-in-time
Notes payable to related parties	`NotesPayableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Notes payable to related parties	`NotesPayableRelatedPartiesNoncurrent`	$6.20M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$33.52M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$32.78M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$31.66M	USD	Point-in-time
Deferred tax liabilities, net	`DeferredIncomeTaxLiabilitiesNet`	-	USD	Point-in-time
Deferred tax liabilities, net	`DeferredIncomeTaxLiabilitiesNet`	$2.88M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$4.92M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$333.00K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$39.82M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$47.53M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$38.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$162.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$227.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$185.32M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$960.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$959.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$1.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$165.67M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$160.38M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$605.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-196.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.12M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$146.75M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$110.21M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$410.60M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-5.61M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-3.10M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-2.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$86.04M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$135.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.68M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$328.97M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$270.20M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$632.06M	USD	Point-in-time

Income Statement 130 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$786.36M	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$207.17M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$603.38M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$690.89M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$657.61M	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$817.08M	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$251.52M	USD	1 Quarter
Physician and practice expense	`PhysicianAndPracticeExpense`	$521.11M	USD	3 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$467.06M	USD	3 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$190.06M	USD	1 Quarter
Physician and practice expense	`PhysicianAndPracticeExpense`	$160.43M	USD	1 Quarter
Physician and practice expense	`PhysicianAndPracticeExpense`	$629.49M	USD	Annual
Physician and practice expense	`PhysicianAndPracticeExpense`	$622.63M	USD	Annual
Physician and practice expense	`PhysicianAndPracticeExpense`	$527.92M	USD	Annual
Cost of platform	`CostOfPlatform`	$131.01M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$73.23M	USD	Annual
Cost of platform	`CostOfPlatform`	$77.13M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$105.01M	USD	Annual
Cost of platform	`CostOfPlatform`	$35.31M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$95.26M	USD	Annual
Cost of platform	`CostOfPlatform`	$25.24M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$11.34M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$7.38M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$2.71M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$9.16M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$18.95M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$4.59M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$11.74M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$41.83M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$33.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$41.50M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$29.20M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$216.56M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.79M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$44.02M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$457.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.07M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.39M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.84M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$466.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.43M	USD	Annual
Total operating expenses	`OperatingExpenses`	$264.33M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$655.45M	USD	Annual
Total operating expenses	`OperatingExpenses`	$888.98M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$770.30M	USD	Annual
Total operating expenses	`OperatingExpenses`	$582.16M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$791.70M	USD	Annual
Total operating expenses	`OperatingExpenses`	$198.63M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$25.38M	USD	Annual
Operating income	`OperatingIncomeLoss`	$8.54M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$-12.81M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$-198.09M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$16.06M	USD	Annual
Operating income	`OperatingIncomeLoss`	$2.15M	USD	Annual
Operating income	`OperatingIncomeLoss`	$21.22M	USD	3 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-1.48M	USD	3 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-6.42M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-504.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-6.91M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-1.92M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-292.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-885.00K	USD	3 Qtrs
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.15M	USD	Annual
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.10M	USD	1 Quarter
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.26M	USD	Annual
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-198.97M	USD	3 Qtrs
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$19.74M	USD	3 Qtrs
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$23.46M	USD	Annual
Income (loss) before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.04M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-7.44M	USD	Annual
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-8.56M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-76.00K	USD	Annual
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-20.21M	USD	3 Qtrs
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-7.39M	USD	3 Qtrs
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-2.21M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$1.21M	USD	Annual
Net income (loss)	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.33M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-10.89M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$7.95M	USD	Annual
Net income (loss)	`ProfitLoss`	$5.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.19M	USD	Annual
Net income (loss)	`ProfitLoss`	$30.90M	USD	Annual
Net income (loss)	`ProfitLoss`	$16.60M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.12M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-299.00K	USD	Annual
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.51M	USD	3 Qtrs
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-255.00K	USD	3 Qtrs
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-85.00K	USD	1 Quarter
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-340.00K	USD	Annual
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.15M	USD	Annual
Less: Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.78M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$-3.04M	USD	Annual
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$16.68M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$-9.12M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$-176.25M	USD	3 Qtrs
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$31.24M	USD	Annual
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$8.24M	USD	Annual
Net income (loss) attributable to Privia Health Group, Inc	`NetIncomeLoss`	$27.38M	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$0.29	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$0.17	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$-0.03	USD	Annual
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$0.09	USD	Annual
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$-1.74	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$0.33	USD	Annual
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in usd per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$0.33	USD	Annual
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$-0.03	USD	Annual
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$0.17	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$0.29	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.74	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$0.09	USD	Annual
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in usd per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.88M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.95M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.93M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.90M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.58M	shares	3 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.95M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.95M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.95M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.90M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.58M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.93M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.88M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.95M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.95M	shares	3 Qtrs

Cash Flow Statement 192 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.33M	USD	1 Quarter
Common stock, shares authorized (in share)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in share)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-10.89M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$7.95M	USD	Annual
Net income (loss)	`ProfitLoss`	$5.20M	USD	1 Quarter
Common stock, shares authorized (in share)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in share)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-4.19M	USD	Annual
Net income (loss)	`ProfitLoss`	$30.90M	USD	Annual
Net income (loss)	`ProfitLoss`	$16.60M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.12M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Common stock, shares issued (in usd per share)	`CommonStockSharesIssued`	95.93M	shares	Point-in-time
Common stock, shares issued (in usd per share)	`CommonStockSharesIssued`	106.23M	shares	Point-in-time
Common stock, shares issued (in usd per share)	`CommonStockSharesIssued`	95.99M	shares	Point-in-time
Common stock, shares outstanding (in usd per share)	`CommonStockSharesOutstanding`	95.93M	shares	Point-in-time
Depreciation	`Depreciation`	$429.00K	USD	Annual
Depreciation	`Depreciation`	$895.00K	USD	3 Qtrs
Common stock, shares outstanding (in usd per share)	`CommonStockSharesOutstanding`	95.99M	shares	Point-in-time
Depreciation	`Depreciation`	$1.19M	USD	Annual
Depreciation	`Depreciation`	$784.00K	USD	Annual
Common stock, shares outstanding (in usd per share)	`CommonStockSharesOutstanding`	106.23M	shares	Point-in-time
Depreciation	`Depreciation`	$869.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$643.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$642.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$482.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$483.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$643.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$120.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$100.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$147.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$100.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$134.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$100.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$332.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$207.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$228.46M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$363.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$484.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.94M	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-20.42M	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$716.00K	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-7.77M	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-258.00K	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-7.83M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-734.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-320.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.78M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.14M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.18M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.57M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$962.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-3.34M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.97M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$151.00K	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.19M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-2.24M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-258.00K	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.43M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.09M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.06M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.14M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.46M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-983.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.71M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$9.50M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$5.72M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.25M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.06M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$118.00K	USD	3 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$30.88M	USD	3 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$38.19M	USD	3 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$24.54M	USD	Annual
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$-2.18M	USD	Annual
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$15.57M	USD	Annual
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$-3.28M	USD	Annual
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$815.00K	USD	3 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$1.72M	USD	Annual
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$2.00M	USD	Annual
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$1.77M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInDueToRelatedParties`	$30.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInDueToRelatedParties`	$-1.93M	USD	Annual
Accounts payable	`IncreaseDecreaseInDueToRelatedParties`	$-3.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$10.03M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$404.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.26M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$4.84M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-14.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$672.00K	USD	Annual
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.25M	USD	Annual
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$67.38M	USD	3 Qtrs
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$24.36M	USD	Annual
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$42.23M	USD	3 Qtrs
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$38.89M	USD	Annual
Taxes payable	`CashAcquiredFromAcquisition`	-	USD	Annual
Taxes payable	`CashAcquiredFromAcquisition`	$55.00K	USD	Annual
Taxes payable	`CashAcquiredFromAcquisition`	-	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.71M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$396.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$380.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$380.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$220.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-380.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-380.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.71M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-165.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-396.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$106.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$108.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$108.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$648.00K	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	3 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.69M	USD	3 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Disposals of PP&E	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Disposals of PP&E	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Disposals of PP&E	`RepaymentsOfRelatedPartyDebt`	$15.25M	USD	Annual
Business Acquisitions, net of cash acquired	`ProceedsFromRelatedPartyDebt`	$15.25M	USD	Annual
Business Acquisitions, net of cash acquired	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Business Acquisitions, net of cash acquired	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$875.00K	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$656.00K	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$30.00M	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$656.00K	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Cash flows from financing activities	`ProceedsFromNotesPayable`	-	USD	Annual
Cash flows from financing activities	`ProceedsFromNotesPayable`	-	USD	Annual
Cash flows from financing activities	`ProceedsFromNotesPayable`	$35.00M	USD	Annual
Proceeds from initial public offering	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Proceeds from initial public offering	`PaymentsOfDebtIssuanceCosts`	$490.00K	USD	3 Qtrs
Proceeds from initial public offering	`PaymentsOfDebtIssuanceCosts`	$618.00K	USD	Annual
Proceeds from initial public offering	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Proceeds from initial public offering	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	-	USD	3 Qtrs
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	$10.00M	USD	Annual
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	$10.00M	USD	3 Qtrs
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	-	USD	Annual
Line of credit payments	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Line of credit payments	`RepaymentsOfLinesOfCredit`	$10.00M	USD	3 Qtrs
Line of credit payments	`RepaymentsOfLinesOfCredit`	$10.00M	USD	Annual
Line of credit payments	`RepaymentsOfLinesOfCredit`	-	USD	3 Qtrs
Line of credit payments	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$210.50M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-767.00K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-548.00K	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$15.36M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-10.87M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$41.30M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$20.44M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$277.48M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.74M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$7.78M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.19M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$362.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.67M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.19M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$362.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.67M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Interest paid.	`InterestPaidNet`	$1.93M	USD	Annual
Interest paid.	`InterestPaidNet`	$3.72M	USD	Annual
Interest paid.	`InterestPaidNet`	$9.20M	USD	Annual
Interest paid.	`InterestPaidNet`	$1.60M	USD	3 Qtrs
Interest paid.	`InterestPaidNet`	$855.00K	USD	3 Qtrs
Line of credit payments	`IncomeTaxesPaidNet`	$316.00K	USD	Annual
Line of credit payments	`IncomeTaxesPaidNet`	$381.00K	USD	Annual
Line of credit payments	`IncomeTaxesPaidNet`	$27.00K	USD	Annual
Line of credit payments	`IncomeTaxesPaidNet`	$451.00K	USD	3 Qtrs
Line of credit payments	`IncomeTaxesPaidNet`	$371.00K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`ConversionOfNotesPayableToRelatedPartiesToCapitalContribution`	$13.26M	USD	Annual
Cash and cash equivalents at beginning of period	`ConversionOfNotesPayableToRelatedPartiesToCapitalContribution`	$4.70M	USD	Annual

Stockholders Equity 53 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$86.04M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$135.05M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.68M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$33.00K	USD	1 Quarter
Merger of related party	`AdjustmentsToAdditionalPaidInCapitalRelatedPartyMerger`	$6.50M	USD	Annual
Capital contribution	`AdjustmentsToAdditionalPaidInCapitalCapitalContribution`	$4.70M	USD	Annual
Capital contribution	`AdjustmentsToAdditionalPaidInCapitalCapitalContribution`	$13.26M	USD	Annual
Stock option exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	54,268.00	shares	Annual
Stock option exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	0.00	shares	Annual
Stock option exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	53,079.00	shares	Annual
Stock option exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	328,323.00	shares	3 Qtrs
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExercised`	$615.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExercised`	$108.00K	USD	Annual
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExercised`	$108.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExercised`	$106.00K	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$484.00K	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$207.00K	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$202.56M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$25.80M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$101.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.94M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.33M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-10.89M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$7.95M	USD	Annual
Net income (loss)	`ProfitLoss`	$5.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.19M	USD	Annual
Net income (loss)	`ProfitLoss`	$30.90M	USD	Annual
Net income (loss)	`ProfitLoss`	$16.60M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.12M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$86.04M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$135.05M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.68M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.